TY - JOUR
T1 - Recent advances in microcatheter technology for the treatment of chronic total occlusions
AU - Vemmou, Evangelia
AU - Nikolakopoulos, Ilias
AU - Xenogiannis, Iosif
AU - Megaly, Michael
AU - Hall, Allison
AU - Wang, Yale
AU - Chavez, Ivan
AU - Garcia, Santiago
AU - Burke, M. Nicholas
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
ES Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, and Medtronic; research support from Regeneron and Siemens. Shareholder: MHI Ventures. Board of Trustees: Society of Cardiovascular Angiography and Interventions. S Garcia is a consultant for Medtronic, Abbott Vascular, Edwards, Surmodics and Osprey Medical. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/4/3
Y1 - 2019/4/3
N2 - Introduction: Use of a microcatheter is essential for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Several microcatheters have recently been introduced in clinical practice aiming to improve deliverability and resistance to deformation. Areas covered: We review the technical characteristics of several new microcatheters (Mamba, Mamba Flex, Teleport Control, Teleport, Nhancer Rx, Sasuke, and ReCross) and compare them with existing microcatheters. Expert opinion: The recently developed microcatheters offer additional options for guidewire support during CTO PCI. Accumulation of clinical experience and performance of comparative effectiveness studies are needed for better understanding the role of these devices in contemporary CTO PCI.
AB - Introduction: Use of a microcatheter is essential for chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Several microcatheters have recently been introduced in clinical practice aiming to improve deliverability and resistance to deformation. Areas covered: We review the technical characteristics of several new microcatheters (Mamba, Mamba Flex, Teleport Control, Teleport, Nhancer Rx, Sasuke, and ReCross) and compare them with existing microcatheters. Expert opinion: The recently developed microcatheters offer additional options for guidewire support during CTO PCI. Accumulation of clinical experience and performance of comparative effectiveness studies are needed for better understanding the role of these devices in contemporary CTO PCI.
KW - Microcatheter
KW - chronic total occlusion
KW - equipment
KW - percutaneous coronary intervention
KW - techniques
UR - http://www.scopus.com/inward/record.url?scp=85064588923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064588923&partnerID=8YFLogxK
U2 - 10.1080/17434440.2019.1602039
DO - 10.1080/17434440.2019.1602039
M3 - Article
C2 - 30929525
AN - SCOPUS:85064588923
VL - 16
SP - 267
EP - 273
JO - Expert Review of Medical Devices
JF - Expert Review of Medical Devices
SN - 1743-4440
IS - 4
ER -